A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation

Clinical trial NCT04165031 · TERMINATED

Trial details

NCT number: NCT04165031
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Non-Small Cell Lung Cancer Colorectal Cancer

Start date: 2019-11-28
Primary completion: 2020-10-30
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.